James Biagi

3.8k total citations
10 papers, 109 citations indexed

About

James Biagi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James Biagi has authored 10 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James Biagi's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatitis Pathology and Treatment (3 papers). James Biagi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (4 papers) and Pancreatitis Pathology and Treatment (3 papers). James Biagi collaborates with scholars based in Canada, France and Australia. James Biagi's co-authors include Karen Spithoff, B. Cummings, Derek J. Jonker, Craig C. Earle, Scott R. Berry, Jaclyn Beca, Scott Gavura, Kelvin Chan, Brandon M. Meyers and Deborah E. Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

James Biagi

10 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Biagi Canada	5	87	44	42	40	21	10	109
Claire Jouffroy-Zeller France	4	102 1.2×	32 0.7×	42 1.0×	40 1.0×	26 1.2×	4	110
Victoria Manax United States	4	98 1.1×	20 0.5×	36 0.9×	36 0.9×	25 1.2×	8	104
Joerg Rathmann United States	4	84 1.0×	26 0.6×	60 1.4×	31 0.8×	28 1.3×	8	110
Takahiro Utsumi Japan	7	112 1.3×	58 1.3×	83 2.0×	11 0.3×	9 0.4×	21	159
T. de Rooij Netherlands	4	112 1.3×	80 1.8×	64 1.5×	12 0.3×	29 1.4×	9	124
Jasnoor Malhotra United States	7	69 0.8×	24 0.5×	82 2.0×	36 0.9×	7 0.3×	26	138
Halil Kara Türkiye	7	36 0.4×	74 1.7×	26 0.6×	63 1.6×	6 0.3×	29	149
Iori Motoo Japan	6	49 0.6×	29 0.7×	42 1.0×	17 0.4×	14 0.7×	22	87
K. Taku Japan	6	68 0.8×	41 0.9×	48 1.1×	12 0.3×	22 1.0×	12	107
Angela Stefania Ribecco Italy	7	59 0.7×	12 0.3×	25 0.6×	21 0.5×	8 0.4×	13	91

Countries citing papers authored by James Biagi

Since Specialization

Citations

This map shows the geographic impact of James Biagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Biagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Biagi more than expected).

Fields of papers citing papers by James Biagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Biagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Biagi. The network helps show where James Biagi may publish in the future.

Co-authorship network of co-authors of James Biagi

This figure shows the co-authorship network connecting the top 25 collaborators of James Biagi. A scholar is included among the top collaborators of James Biagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Biagi. James Biagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Lambert, Aurélien, Julia Salleron, Alexandre Harlé, et al.. (2024). Impact of Positive Resection Margins on Recurrence and Survival After Resection and Adjuvant Chemotherapy in Pancreatic Cancer. Annals of Surgery. 283(4). 651–658. 1 indexed citations

Biagi, James, Roxanne Cosby, Tarek Elfiki, et al.. (2023). Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline. Current Oncology. 30(7). 6575–6586. 5 indexed citations

Dai, Wei Fang, Steven Habbous, Ronak Saluja, et al.. (2023). Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival. Clinical Oncology. 35(5). e303–e311. 2 indexed citations

Salleron, Julia, Thierry Conroy, Frédéric Marchal, et al.. (2022). Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial. Cancers. 14(16). 3945–3945. 3 indexed citations

Bachet, Jean‐Baptiste, et al.. (2022). 1297P Adjuvant gemcitabine is as efficient as mFOLFIRINOX in patients with GemPred+ tumor signature and resected pancreatic adenocarcinoma (PDAC): An ancillary study of the PRODIGE-24 clinical trial. Annals of Oncology. 33. S1136–S1136. 3 indexed citations

Conroy, Thierry, Pascal Hammel, Anthony Turpin, et al.. (2021). LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC). Annals of Oncology. 32. S1334–S1334. 11 indexed citations

Chan, Kelvin, Helen Guo, Sierra Cheng, et al.. (2019). Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis. Cancer Medicine. 9(1). 160–169. 59 indexed citations

Spithoff, Karen, B. Cummings, Derek J. Jonker, & James Biagi. (2014). Chemoradiotherapy for Squamous Cell Cancer of the Anal Canal: A Systematic Review. Clinical Oncology. 26(8). 473–487. 19 indexed citations

Penniment, Michael, Jennifer A. Harvey, Rebecca Wong, et al.. (2014). Best Practice in Advanced Esophageal Cancer: A Report on Trans-Tasman Radiation Oncology Group TROG 03.01 and NCIC CTG ES.2 Multinational Phase 3 Study in Advanced Esophageal Cancer (OC) Comparing Quality of Life (QOL) and Palliation of Dysphagia in Patients Treated With Radiation Therapy (RT) or Chemoradiation Therapy (CRT). International Journal of Radiation Oncology*Biology*Physics. 90(1). S3–S3. 5 indexed citations

10.

Biagi, James, et al.. (2009). Assessing compliance with practice treatment guidelines by treatment centers and the reasons for noncompliance. Journal of Clinical Oncology. 27(15_suppl). e17506–e17506. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact